文献速递脊柱外科

颈椎间盘置换术后使用非甾体抗炎药预防与异位骨化发生率降低相关

Postoperative NSAID Prophylaxis is Associated With Decreased Rates of Heterotopic Ossification following Cervical Disc Arthroplasty.
PubMed 文献 · Spine (Phila Pa 1976) · 2026-01-16

这项回顾性队列研究纳入140例颈椎间盘置换患者,42.3%发生异位骨化。多因素分析显示较高BMI与异位骨化风险增加相关,而术后早期使用非甾体抗炎药与异位骨化发生率降低相关。异位骨化阳性与阴性组临床结局无显著差异。

要点

  • 140例颈椎间盘置换患者中42.3%发生异位骨化。
  • 较高BMI与异位骨化风险增加相关,术后使用非甾体抗炎药与风险降低相关。
  • 异位骨化阳性与阴性组患者报告结局、并发症和再手术率无显著差异。

核心结论

  • 多因素分析显示较高BMI与颈椎间盘置换术后异位骨化风险增加相关,而术后早期使用非甾体抗炎药与异位骨化发生率降低相关。
  • 异位骨化存在组与不存在组的临床结局相似。
  • 作者认为这些发现支持非甾体抗炎药预防在减少颈椎间盘置换术后异位骨化发生和指导术后管理中的潜在作用。

研究设计与样本

  • 回顾性队列研究,在单中心学术中心利用维护的手术登记系统进行回顾性复习。
  • 纳入接受颈椎间盘置换且至少有1至2年影像学随访的患者。
  • 收集人口学变量、BMI、植入物类型、手术节段及术后48小时内非甾体抗炎药使用情况(任何原因与专门用于异位骨化预防)。
  • 采用McAfee分级对影像学上的异位骨化严重程度进行评级。
  • 进行两项逻辑回归分析评估变量与异位骨化形成之间的关联。

主要发现

  • 140例患者中42.3%发生异位骨化。
  • 异位骨化存在与较高年龄(P=0.015)、较高BMI(P=0.004)以及较低的非甾体抗炎药使用率相关,包括总体使用(P=0.033)和专门用于异位骨化预防(P=0.01)。
  • 逻辑回归证实较高BMI与异位骨化风险增加相关,而术后使用非甾体抗炎药与风险降低相关。
  • 异位骨化阳性组和阴性组的临床结局与患者报告结局均随时间显著改善,两组在结局、并发症或再手术方面无显著差异。

临床怎么用

  • 作者认为这些发现支持非甾体抗炎药预防在减少颈椎间盘置换术后异位骨化发生和指导术后管理中的潜在作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY DESIGN: Retrospective cohort study. OBJECTIVE: To identify factors associated with heterotopic ossification (HO) formation following cervical disc arthroplasty (CDA), including postoperative non-steroidal anti-inflammatory drug (NSAID) use. SUMMARY OF BACKGROUND DATA: CDA preserves segmental motion in treating cervical degenerative disc disease but is susceptible to HO formation, which may compromise surgical outcomes. While NSAID prophylaxis is well-established in total hip arthroplasty to reduce HO risk, its role in CDA remains underexplored. MATERIALS AND METHODS: A retrospective review was conducted at a single academic center using a maintained surgical registry. Patients undergoing CDA with at least 1 to 2 years of radiographic follow-up were included. Demographic variables, BMI, implant type, operative levels, and NSAID use (any reason vs . specifically for HO prophylaxis) within 48 hours postoperatively were collected. Radiographs were graded for HO severity using the McAfee classification. Two logistic regression analyses assessed associations between variables and HO formation. Patient-reported outcome measures (PROMs) and rates of complications and reoperations were compared between HO-positive and HO-negative groups. RESULTS: Among 140 patients, 42.3% developed HO. HO presence was associated with higher age ( P =0.015), higher BMI ( P =0.004), and lower NSAID use both overall ( P =0.033) and specifically for HO prophylaxis ( P =0.01). Logistic regression confirmed that higher BMI was associated with increased HO risk, while postoperative NSAID use was associated with reduced risk. Clinical outcomes and PROMs improved significantly over time in both HO+ and HO- groups, with no significant differences in outcomes, complications, or reoperations. CONCLUSION: Following multivariate analysis, higher BMI is associated with increased risk of HO following CDA, while early postoperative NSAID use is associated with a lower incidence. Clinical outcomes were similar between HO presence and absence groups. These findings support the potential role of NSAID prophylaxis in reducing HO development and guiding postoperative management following CDA. LEVEL OF EVIDENCE: Level 3.

来源:Spine (Phila Pa 1976),查看原文。版权归原作者所有。

引用

  1. Ehrlich AM, Owusu-Sarpong S, Asada T, et al. Postoperative NSAID Prophylaxis is Associated With Decreased Rates of Heterotopic Ossification following Cervical Disc Arthroplasty. Spine (Phila Pa 1976). 2026. PMID: 41549724. doi:10.1097/BRS.0000000000005627

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。